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Abstract 
The author reports a very rare case of spindle cell carcinoma of the common bile 
duct with an emphasis on immunohistochemical features. A 65-year-old man was 
admitted to our hospital because of jaundice. Imaging modalities revealed a tumor  
of the common bile duct, and bile cytology demonstrated malignant cells. A 
pancreatico-duodenectomy was performed. Grossly, an elevated tumor (15 × 10 × 3 mm) 
was present in the middle portion of the common bile duct. Microscopically, the tumor 
consisted of well-differentiated adenocarcinoma (20% in area) and spindle cell 
carcinoma (80% in area). There were gradual transitions between the two. The tumor 
cells invaded into the serosa. Immunohistochemically, the spindle cell carcinoma 
element was positive for four types of pancytokeratins, cytokeratin 7 (CK7), CK8, CK18, 
CK19, CK20, epithelial membrane antigen, vimentin, p53 protein, Ki-67 (labeling = 
52%), and CEA. It was negative for high-molecular-weight CK, CK5/6, CK14, p63, 
neuron-specific enolase chromogranin, synaptophysin, CD56, CA19-9, CD34, desmin, 
S100 protein, myoglobin, α-smooth muscle antigen, CD34, CD68 and KIT. The 
adenocarcinoma element showed similar immunoreactivity except for negative vimentin, 
and positive CA19-9. The present case is the first report of spindle cell carcinoma of the 
common bile duct demonstrating an extensive immunohistochemistry. The spindle cell 
carcinoma in the present case may be derived from sarcomatous transformation of the 
adenocarcinoma element. CK20 newly emerges in the development of spindle cell 
carcinoma of the common bile duct. 
Introduction 
Sarcomatoid carcinoma of the extra- and intrahepatic bile ducts is very rare; only a few 
case reports and case studies of small series have been reported [1–9]. In particular,  
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sarcomatoid carcinoma of the common bile duct is extremely rare [6–9]. Spindle cell 
carcinoma, a variant of sarcomatoid carcinoma, is also extremely rare in the common bile 
duct; only two case reports have been published in the English language literature [8, 9]. 
There have been no reports examining extensive immunohistochemical features in 
sarcomatoid carcinoma of the biliary tree. The author herein presents a case of spindle 
cell carcinoma of the common bile duct with an emphasis on immunohistochemical 
features. 
Case Report 
A 65-year-old man was admitted to our hospital because of jaundice. Imaging modalities including 
ERCP, CT, and MRI revealed a tumor of the common bile duct, and bile cytology identified malignant 
cells. A pancreatico-duodenectomy was performed. Grossly, an elevated tumor (15 × 10 × 3 mm) was 
present in the middle portion of the common bile duct (fig. 1). Microscopically, the tumor consisted of 
well-differentiated adenocarcinoma (20% in area) and spindle cell carcinoma (80% in area) (fig. 2). 
There were gradual transitions between the two. The tumor cells invaded into the serosa.  
An immunohistochemical study was performed, using the Dako Envision method (Dako Corp., 
Glostrup, Denmark), as previously described [10–14]. The antigens examined and their results are 
shown in table 1. Immunohistochemically, the spindle cell carcinoma element was positive for four 
types of pancytokeratins, cytokeratin 7 (CK7) (fig. 3a), CK8, CK18 (fig. 3b), CK19, CK20, epithelial 
membrane antigen, vimentin (fig. 3c), p53 protein (fig. 3d), Ki-67 (labeling = 52%), and CEA (fig. 3e). It 
was negative for high-molecular-weight CK, CK5/6, CK14, p63, neuron-specific enolase chromogranin, 
synaptophysin, CD56, CA19-9, CD34, desmin, S100 protein, myoglobin, α-smooth muscle antigen, 
CD34, CD68 and KIT. The adenocarcinoma element showed similar immunoreactivity, except for 
negative vimentin and positive CA19-9 (table 1). 
Discussion 
Only two cases of spindle cell carcinoma of the common bile duct have been 
reported in the English language literature, to the best of the author’s knowledge [8, 9]. 
Oikawa et al. [8] reported a case of sarcomatous carcinoma of the common bile duct 
composed of spindle cells, giant cells, and adenocarcinoma cells. Their case was 
immunohistochemically positive for pancytokeratins, epithelial membrane antigen and 
vimentin. The diagnosis was spindle cell and giant cell undifferentiated carcinoma [8]. 
Nakanishi et al. [9] reported spindle cell carcinoma of the common bile duct at the 
hepatic hilus. Their case was composed of spindle cells and adenocarcinoma cells, and 
immunohistochemically positive for two kinds of pancytokeratin [9]. 
The present tumor was composed of a spindle cell carcinoma element (80%  
in area) and a well-differentiated adenocarcinoma element (20% in area). 
Immunohistochemically, the tumor cells were positive for a wide range of CK, CEA 
and vimentin. They were also positive for p53 protein and Ki-67 antigen with high 
labeling indices. In contrast, they were negative for other mesenchymal markers and 
neuroendocrine markers. Therefore, the present tumor of the common bile duct is not a 
sarcoma but a carcinoma. Thus, spindle cell carcinoma was the correct diagnosis in the 
present study. 
Sarcomatous transformation of carcinoma can occur in any carcinoma, though the 
frequency is very rare. In the present case also, the carcinoma was composed of spindle 
cell carcinoma and adenocarcinoma. There were gradual transitions between the two.  
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These findings strongly suggest that the spindle cell carcinoma element is derived from 
sarcomatous transformation of the adenocarcinoma element. The immunohistochemical 
data support this hypothesis in the present case. 
There have been few studies of immunohistochemistry in spindle cell carcinoma of the 
common bile duct [8, 9], and extensive immunohistochemical studies of sarcomatoid 
carcinoma of the biliary tree have been performed. CK profiling has not been performed 
in sarcomatoid carcinoma of the bile ducts. It is well known that bile duct epithelium 
shows CK7, CK8, CK18 and CK19. In the present study, these CKs and CK20 were 
positive, indicating that CK20 emerged during the carcinogenesis of the present tumor. 
Positive expression of vimentin indicates a sarcomatous nature of the present carcinoma. 
Positive expression of CEA suggests an adenocarcinomatous nature of the present spindle 
cell carcinoma. 
Mesenchymal markers including S100 protein, α-smooth muscle actin, CD34, 
myoglobin and desmin were absent in the present tumor, indicating that it was not a 
sarcoma but a carcinoma and that these antigens did not emerge during the spindle cell 
transformation of the adenocarcinoma of the present case. The present case was negative 
for neuroendocrine markers, suggesting that these antigens were absent from spindle cell 
carcinoma of the biliary tree. The present study also showed p53 protein and Ki-67 
antigen. High Ki-67 labeling predict poor prognosis. In the present case, Ki-67 labeling of 
both elements was very high, suggesting a poor prognosis. The present tumor was free of 
neuroendocrine markers (chromogranin, synaptophysin, neuron-specific enolase, and 
CD56). The present findings indicate that the present tumor was not a neuroendocrine 
tumor. The present case was negative for CD34, CD68 and KIT, suggesting that the 
present tumor was not a KIT-positive tumors such as extragastrointestinal stromal tumor 
or other carcinomas and sarcomas. 
In summary, the present case is the first report of spindle cell carcinoma of the 
common bile duct demonstrating an extensive immunohistochemistry. The spindle cell 
carcinoma in the present case may be derived from sarcomatous transformation of an 
adenocarcinoma element. 
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Table 1. Immunohistochemical reagents and results 
Results  Antigens Antibodies   
(clone) 
Sources 
spindle cell  
carcinoma 
adeno-
carcinoma 
Pancytokeratin  AE1/3  Dako Corp., Glostrup, Denmark  +++  +++ 
Pancytokeratin polyclonal  wide  Dako  ++  +++ 
Pancytokeratin  KL-1  Immunotech, Marseille, France  +++  +++ 
Pancytokeratin  CAM5.2  Becton Dickinson Co., CA, USA  ++  +++ 
HMWCK 34βE12  Dako  –  – 
CK5/6 D5/16  Dako  –  – 
CK7 N1626 Dako  +++  +++ 
CK8 35βH11  Dako  ++  ++ 
CK14  LL002  Novocastra, Newcastle upon Tyne, UK  –  – 
CK18 DC10  Dako  +++  +++ 
CK19  RCK 108  Progen, Heidelberg, Germany  ++  ++ 
CK20 K20.8  Dako  +  ++ 
EMA E29  Dako  + + 
Vimentin Vim  3B4  Dako  ++  – 
CEA polyclonal  Dako  + ++ 
Desmin D33  Dako  –  – 
S100 protein  polyclonal  Dako  –  – 
Myoglobin polyclonal  Dako  –  – 
ASMA 1A4  Dako  –  – 
CD34  NU-4A1  Nichirei, Tokyo, Japan  –  – 
p53 protein  DO-7  Dako  +++  +++ 
p63 polyclonal  Dako  –  – 
Ki-67 MIB-I  Dako  52%  46% 
CA19-9  NA19-9  TFB Lab, Tokyo, Japan  –  + 
Chromogranin DAK-A3  Dako  –  – 
Synaptophysin polyconal  Dako  –  – 
NSE BBS/NC/VI-H14  Dako  –  – 
CD56 UJ13A  Dako  –  – 
CD68 KP-1  Dako  –  – 
KIT polyclonal  Dako  –  – 
+++ = 67–100% positive; ++ = 33–67% positive; + = 1–33% positive; – = negative.  
HMWCK = High-molecular-weight cytokeratin; CK = cytokeratin; EMA = epithelial membrane 
antigen; CA19-9 = carcinoma antigen 19-9; CEA = carcinoembryonic antigen; ASMA = α-smooth muscle 
antigen; NSE = neuron-specific enolase. 
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Fig. 1. Gross features of the common bile duct tumor. An elevated tumor is seen (central part). 
 
 
 
Fig. 2. a Microscopic features. The spindle cell carcinoma element (upper) and the adenocarcinoma 
element (lower) are seen. There is a gradual transition between the two. HE, ×20. b High power view of 
the spindle cell carcinoma element. Malignant features are apparent. There are many mitotic figures. 
HE, ×100. 
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Fig. 3. a Positive reaction of CK7 in the spindle cell carcinoma element. Immunostaining, ×100. 
b Positive reaction of CK18 in the spindle cell carcinoma element. Immunostaining, ×100. c Positive 
reaction of vimentin in the spindle cell carcinoma element. Immunostaining, ×100. d Positive reaction 
of p53 in the spindle cell carcinoma element. Immunostaining, ×100. e Positive reaction of CEA in the 
spindle cell carcinoma element. Immunostaining, ×100. 
 
References 
1 Nakajima T, Tajima Y, Sugano I, Nagao K, Kondo Y, Wada K: Intrahepatic cholangiocarcinoma with 
sarcomatous changes: clinicopathologic and immunohistochemical evaluation of seven cases. Cancer 
1993;72:1872–1877. 
2 Sasaki M, Nakanuma Y, Nagai Y, Nonomura A: Intrahepatic cholangiocarcinoma with sarcomatous 
transformation: an autopsy case. J Clin Gastroenterol 1991;13:220–225.  
Case Rep Gastroenterol 2010;4:374–380 
DOI: 10.1159/000320674 
Published online: 
September 18, 2010
© 2010 S. Karger AG, Basel 
ISSN 1662–0631 
www.karger.com/crg 
 
 
380
3 Terada T, Notsumata K, Nakanuma Y: Biliary carcinosarcoma arising in nonparasitic simple cyst of the liver. 
Virchows Arch 1994;424:331–335. 
4 Shimada M, Takenaka K, Rikkimaru T, Hamatsu T, Yamashita Y, Kajiyama K, Taguchi K, Shirabe K, 
Sugimachi K: Characteristics of sarcomatous cholangiocarcinoma of the liver. Hepatogastroenterology 
2000;47:956–961. 
5 Shinoda M, Shimizu M, Mukai M, Tanabe M, Hashigichi N, Oda M, Kitajima M: Spindle cell carcinoma of the 
intrahepatic bile duct in a patient with primary sclerosing cholangitis. J Gastroenterol 2003;38:1091–1096. 
6 Yoon GS, Choi DL: Sarcomatoid carcinoma of the common bile duct: a case report. Hepatogastroenterology 
2004;51:106–109. 
7 Albores Saavedra J, Gridler DJ, Wu J, Hensen DE, Goodman ZD: Giant cell tumor of the extrahepatic biliary 
tree: a clinicopathologic study of 4 cases and comparison with anaplastic spindle and giant cell carcinoma with 
osteoclast-like giant cells. Am J Surg Pathol 2006;30:495–500. 
8 Oikawa H, Oka K, Nagakusa S, Fukunaga M, Sando N, Kashimura J, Hakozaki H: Spindle and giant cell type 
undifferentiated carcinoma arising in the common bile duct: a case report. Pathol Res Pract 2007;203:179–184. 
9 Nakanishi Y, Ito T, Kubota K, Takeda H, Yonemori A, Kawakami H, Zen Y, Kondo S: Spindle cell-type 
undifferentiated carcinoma of the common bile duct of the hepatic hilus: report of a case. Surg Today 
2007;37:708–712. 
10 Terada T, Kawaguchi M: Primary clear cell adenocarcinoma of the peritoneum. Tohoku J Exp Med 
2005;206:271–275. 
11 Terada T, Kawaguchi M, Furukawa K, Sekido Y, Osamura Y: Minute mixed ductal-endocrine carcinoma of the 
pancreas with predominant intraductal growth. Pathol Int 2002;52:740–746. 
12 Terada T: Primary multiple extragastrointestinal stromal tumors of the omentum with different mutations of 
c-kit gene. World J Gastroenterol 2008;14:7256–7259. 
13 Terada T: Gastrointestinal stromal tumor of the uterus: a case report with genetic analyses of c-kit and 
PDGFRA genes. Int J Gynecol Pathol 2009;28:29–33. 
14 Terada T: Large endocervical polyp with cartilaginous and osseous metaplasia: a hitherto unreported entity. 
Int J Gynecol Pathol 2009;28:98–100. 